We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Technopath Clinical Diagnostics - An LGC Company

BIOBASE

The BIOBASE Group focuses on the development, production and management of scientific equipment, in vitro diagnosis (... read more Featured Products: More products

Download Mobile App





BIOBASE Displays Range Of Laboratory & Medical Analyzers

By LabMedica International staff writers
Posted on 07 Feb 2018
Print article
The BK6100 auto three-part hematology analyzer (Photo courtesy of BIOBASE).
The BK6100 auto three-part hematology analyzer (Photo courtesy of BIOBASE).
Medical and laboratory products manufacturer, BIOBASE (Jinan, China), showcased its wide range of laboratory & medical analyzers at MEDLAB 2018 held from February 5-8, 2018 in Dubai, UAE. The three-day event saw companies displaying their latest innovations, products and cutting-edge technologies in the IVD, medical laboratory and healthcare market.
 
The BIOBASE Group specializes in eight products areas, including medical diagnosis, biosafety protection, disinfection and sterilization, water purification system, infant care products, cold chain products, software products, and clean room project. The company has obtained patents and expanded marketing for multiple products, such as the self-developed biochemistry analyzer, 107 kinds of reagents, automatic ELISA processor, medical sterilization instruments and biosafety protection equipment. 
 
After participating successfully in the global medical trade show Arab Health 2018 held in Dubai just last week, BIOBASE once again exhibited its product range of chemistry analyzers, auto ELISA processor, hematology analyzers, coagulation analyzers, ESR analyzers, ELISA microplate readers, medical refrigerators and biological safety cabinets at MEDLAB Middle East 2018. The company also displayed other products such as fume hood, autoclaves, microscopes, incubators and reagents at the event.
 
Gold Supplier
Saliva Collection Kit
SpeciMAX Stabilized Saliva Collection Kit
New
3-Part Diff Hematology Analyzer
DLB3
New
Automated Nucleic Acid Extraction System
NuActor
New
High-Throughput Nucleic Acid Extractor
Stream SP96

Print article

Channels

Clinical Chem.

view channel
Image: The analysis pipeline used to investigate associations between blood metabolites, later life brain imaging measures, and genetic risk for Alzheimer’s disease (Photo courtesy of University College London)

Lipid Measurements Show Potential as Alzheimer’s Disease Biomarkers

Brain changes accompanying ageing are varied and can include pathologies that lead to cognitive impairment, the commonest of which is Alzheimer’s disease (AD). Identifying blood-based signatures of brain... Read more

Molecular Diagnostics

view channel
Image: Guidance UTI provides personalized results in less than one day from receipt at lab (Photo courtesy of Pathnostics)

Rapid Result Test for Complicated Urinary Tract Infections Proves Superior to Standard Urine Culture

Complicated urinary tract infections (cUTIs) are a significant burden on individual health and healthcare resources that must be diagnosed and treated early and accurately to reduce the risk of poor outcomes.... Read more

Hematology

view channel
Image: The CS-2500 analyzer features pre-analytic sample checks and four detection methods simultaneously on a single platform – coagulation end-point, chromogenic kinetic analysis, turbidimetric immunoassay and automated platelet aggregation (Photo courtesy of Sysmex)

Microvascular/Endothelial Dysfunction Contributes to Post-COVID Syndrome Pathogenesis

Post-COVID syndrome (PCS) or Long-COVID is an increasingly recognized complication of acute SARS-CoV-2 infection, characterized by persistent fatigue, reduced exercise tolerance chest pain, shortness of... Read more

Industry

view channel
Image: Sales of lateral flow assays in clinical testing are expected to register a CAGR of 5% through 2032 (Photo courtesy of Pexels)

Global Lateral Flow Assays Market to Surpass USD 11.5 Billion by 2032 Due to Evolving Applications

The global lateral flow assays market was valued at USD 7.2 billion in 2021 and is projected to register a CAGR of 4.7% during 2022-2032 to surpass USD 11.7 billion by the end of 2032, driven by the growing... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.